Ultrasound Guided Human Thrombin Injection. A New Modality in the Management of Femoral Artery Pseudo-aneurysms  by Sultan, S et al.
Eur J Vasc Endovasc Surg 22, 542–545 (2001)
doi:10.1053/ejvs.2001.1519, available online at http://www.idealibrary.com on
Ultrasound Guided Human Thrombin Injection. A New Modality in the
Management of Femoral Artery Pseudo-aneurysms
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Objectives: we report our initial results of a prospective study of duplex ultrasound-guided injection (UGTI ) of thrombin
in the management of femoral artery pseudo-aneurysms. We used human thrombin to avoid the increase in the human
antibodies directed against fibrinogen, with the use of bovine thrombus, that preclude further utilisation of the bovine
fibrin glue during cardio-thoracic surgery.
Methods: from 1999 to 2001, 19 patients, aged 69 (range 52–85) years presented with 21 femoral pseudo-aneurysms
were treated. The mean pseudoaneurysm diameter was 30 (15–55) mm. All but two were secondary to cardiac procedures
and the common femoral artery was the injured vessel in all instances. Patients were referred within 2–21 days following
their iatrogenic injury.
Results: immediate thrombosis of the sac occurred in 19 (90%) of the 21 pseudo-aneurysms. After a second injection,
complete occlusion occurred in the remaining two patients. Two patients (CI 95%; 1–19) with three femoral pseudo-
aneurysms developed leg pain. Duplex ultrasound follow-up showed two recurrences (9.5% – CI 95%; 1–19) and both
were treated by repeat UGTI. There was no conversion to surgical repair.
Conclusion: this percutaneous minimally invasive technique is safe and effective in the management of iatrogenic pseudo-
aneurysms in this high-risk group of patients. Human thrombin has significant advantages over bovine thrombin.
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Introduction in blood coagulation abnormalities.15,16,18 We believe
that this is the third report of UGTI in the management
As cardiac intervention escalates so does the incidence of femoral artery pseudo-aneurysms utilising human
thrombin.19of femoral artery pseudo-aneurysms.1,2 Non an-
astomotic pseudoaneurysms most commonly occur
after iatrogenic trauma to the femoral arteries fol-
lowing cardiac catheterisation. The standard method
Patients and Methodsof treatment for these aneurysms is surgical repair.
Percutanous intervention is becoming an alternative Over a 22 months period (July 1999 to June 2001), 19way for managing many vascular complications.1–8 patients were referred to the vascular service in St.Fellmeth in 1991 was the first to describe ultrasound- James’s hospital with 21 femoral pseudoaneurysms.guided compression repair (UGCR).6 Human thrombin There were 9 males and 10 females. The mean ageinjection has several advantages over UGCR. It is less was 69 years with a mean diameter of the pseudo-painful, less time consuming, a higher success rate aneurysm sac of 30 mm (15–55 mm). Patients wereand low incidence of antibodies against fibrinogen.9–18 referred within 2–21 days post-iatrogenic injury.Duplex ultrasound-guided injection (UGTI ) can treat Seven patients were classified according to thecases in which compression of the groin is not feasible, American Association of Anesthiologist as ASA IV.e.g. patients on anticoagulation. Eight patients were on anticoagulation and 11 patientsExposure of humans to bovine thrombin has been were on antiplatelets. Diagnostic duplex ultrasoundassociated with development of antibodies resulting examination was performed with an ATL-HDI 5000
machine using a 5 MHz linear transducer. A duplex
scan and ankle brachial index was performed before∗ Please address all correspondence to: S. Sultan, St. James’s Vascular
Institute, Trinity College, St. James’s Hospital, Dublin 8, Ireland. and after the injection.
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Seventeen patients developed 19 femoral pseudo- Results
aneurysms following cardiac catheterisation. Eleven
pseudoaneurysms developed after coronary angio- Immediate thrombosis of the sac occurred in 19 (90%)
of the twenty-one pseudo-aneurysms. Complete oc-plasty and stenting and 8 after diagnostic coronary
angiogram. A large size sheath (6, 7, 8 French sheath) clusion was obtained in the remaining two after a
second injection two and seven days later. Twenty-in a small CFA was the most prevalent aetiology. Two
cases occurred after diagnostic peripheral angio- one femoral pseudoaneurysms were treated with 25
injections. The human thrombin concentration was 500graphy, both were on anticoagulation with warfarin.
All pseudoaneurysms arose from the common femoral units per 1 ml. The mean volume of thrombin injection
was 3.7 ml (range 1–5 ml). Fifteen pseudoaneurysmsartery (CFA).
were treated with 5 ml, nine pseudoaneurysms with
2 ml and one pseudoaneurysm with 1 ml.
Two patients (CI 95%; 1–19) with three pseudo-
aneurysms (14%) had leg pain with abnormal ankleTechnique
brachial index and distal low flow states on duplex
scan with a flow velocity of blood of 20 cm/s. TheseHuman thrombin, which is collected from healthy
two patients dropped their ankle brachial index byEuropean donors, and prepared with calcium chloride
more than 20%. However, intravenous heparin for 24 hfrom a Tissel kit Immune (AG, Vienna, Austria) and
abolished the leg pain and the arterial flow on duplexheated to 37 °C utilising the fibrinotherm machine
scan returned to normal at 80–100 cm/s. The remaining(Baxter, U.S.A.). The groin area is prepped with alcohol
seventeen patients had a normal pre and post ankleand 20 ml of 1% lignocaine is injected over the desired
brachial index and normal velocity in the arterial treearea. The ultrasound transducer is centred over the
on duplex scan.pseudoaneurysm. Thrombin is loaded in the small
Duplex follow-up showed recurrence (CI 95%: 1–19)syringe with a 21-echo tip Cook needle. This needle
in two cases (9.5%). One patient developed groin painis etched near the tip for enhanced ultrasound visu-
at the 4th day and duplex ultrasound documented thealisation. The needle is inserted at an angle into the
recurrence as well as the second patient at the 7thpseudoaneurysm along the same plane as the trans-
days post UGTI. Both were treated successfully withducer.
a second injection. We observed that there was residualB mode imaging is used to confirm that the needle
thrombus in the thrombosed sac during follow up attip is near the centre of the pseudoaneurysm. Com-
six weeks and complete resorption of the thrombus inpression by the duplex probe during injections is used
almost half of the patients. No complications wereto occlude the feeding tract and prevent escape of the
seen at this time or later presumably that the arterialsolution to the native artery. Thrombin is injected into
defects in the wall of the femoral artery had healed.the pseudoaneurysm. In the majority of cases, this
Anticoagulation or antiplatelet therapy did not in-resulted in almost immediate thrombosis of the
fluence the outcome. We report a 100% clinical successpseudoaneurysm. However, when incomplete throm-
after a second injection. There was no conversion tobosis of the sac occurs, the needle is redirected into the
surgical repair.remaining flow cavity and more thrombin is injected,
avoiding the feeding tract.
Early in our experience patients were kept on bed
rest for 24 h. Later on, with increasing confidence in Discussion
the technique, patients were allowed to leave the
vascular laboratory immediately. Repeat duplex ex- Ultrasound guided thrombin injection (UGTI) is a
aminations were performed at one and six weeks promising treatment for iatrogenic femoral pseudo-
following treatment. aneurysms. In 1986 Cope and Zeit first described the
percutaneous injection of thrombin to treat peripheral
arterial aneurysms.11 Later on, Walker et al. used endo-
vascular approach to deliver thrombin endoluminal
to treat a false aneurysm of the profunda femoralStatistics
artery.12 The technique was not used widely, until
the reports of Kang13 and Liau,14 which showed theMorbidity and recurrence were analysed through con-
fidence interval. We used on line statistical package; advantages of percutaneous thrombin injections in the
treatment of femoral artery pseudoaneurysms. All ofVassarStats at http://faculty.vassar.edu.
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these procedures were done using bovine thrombin with Taylor et al.9 who used compression-guided ultra-
sound as a complementary to thrombin injection inin high concentrations.
cases of failure. Our results mirror the findings ofBovine thrombin preparations are highly im-
Kang et al.13 who had recurrence in five cases inmunogenic and appear to be associated with an in-
comparison to two cases in our study.creased risk of adverse clinical outcomes during
In two patients, the pseudoaneurysm sac was stillsubsequent surgical procedures. Topical bovine throm-
patent after the first injection and required a secondbin is used extensively as a haemostatic agent during
injection 48 h to a week later. This allowed the groincardiovascular surgery. Antibodies developing after
haematoma to settle down and defined the remainingexposure to bovine thrombin have anecdotally been
patent loculus in the pseudoaneurysm. Although theassociated with haemorrhagic complications such as
technique is effective, we encountered difficulty insevere epistaxis, prolonged coagulation tests and de-
determining the exact site of injection: where the an-creased plasma factor V. In this study, we used human
eurysm was deep or the cavity was small or wherethrombin as it is safer because of higher purity20 and
the groin haematoma was large, making it difficult toto avoid the increase in the human antibodies directed
visualise the echo tip on B-mode ultrasound. In suchagainst fibrinogen, thrombin, and factor V, which pre-
situations, the injection was postponed for one week,clude further utilisation of the bovine fibrin glue dur-
until signs of the causative procedure resolved.ing cardio-thoracic surgery.16–18,20,21 Evaluation revealed
Our results depict the findings of Kang et al.,13 wherean inhibitor to bovine thrombin that cross-reacted with
anticoagulation or anti-platelet therapy did not affecthuman thrombin.21 In addition an inhibitor to human
the results of our study. As thrombin works on thecoagulation factor V was identified.20,21 This human
final path of the coagulation cascade and the onlythrombus is collected from healthy European donors
needed element for thrombus formation is fibrinogen.and dried up in the Tissel kit Immune.
Although our experience in patients on anticoagulationUntil December 1998 all our patients were subjected
subjected to UGTI is limited, we believe that humanto ultrasound compression and if this fails they were
thrombus injection will be effective in most cases.3,13operated upon for direct repair of their aneurysms.
Thrombin is a potent pro-inflammatory mediatorWe found that ultrasound guided compression is time
of cytokines that activates the in-vivo coagulationconsuming and painful, has poor results in patients
cascade. However, heparin has a counter effect on thewho are undergoing anticoagulation therapy and can-
signalling of thrombin on the vascular endotheliumnot treat non-compressible pseudo aneurysms with a
through potentiating the effect of anti-thrombin III.15–18large feeder. Typical published success rates are 60%.6
The low flow state that occurred in three limbs thatOur technique is similar to Taylor et al.,9 except for resolved by intravenous heparin might explain the
the use of human thrombin in our study. Liau et al.14 latter.
used bovine thrombus but his technique was much UGTI complications were 14%. The risks are real
different than ours. The technique is similar to Kang and vascular surgeons should be trained in this field
et al.13 in the localisation and injection protocol, but as this technique falls within the armamentarium of
our technical success rate was 90.4% in comparison endovascular intervention. Percutaneous arterial clos-
to 95%. However with a second injection into the ure devices are in common use and they will sub-
pseudoaneurysm sac after 48 h to seven days, we were stantially decreased the incidence of pseudo-
able to achieve a 100% clinical success. aneurysms.22 We recognise that this preliminary report
Kang et al. and Liau et al. in their report had no was not randomised for either the gold standard; the
procedure-related complications, in contrast with our surgical repair, or UGCR and the sample size is small.
initial experience13–15 where two patients with three
femoral pseudoaneurysms developed leg pain and
were found on duplex scanning to have a normal Conclusion
arterial tree with low flow 20 ml/s2 post injection in
two cases and one case had thrombus in the peroneal This percutaneous minimally invasive technique is
artery. Their ankle brachial index dropped by 20%. safe and effective in the management of pseudo-an-
This might be due to spillage of some of the thrombin eurysms in high-risk patients. In spite of 10% initial
to the distal arterial tree. All their symptoms, ankle failure and 14% morbidity, ultrasound guided throm-
brachial indices and duplex findings were normal after bin injection seems effective in the treatment of
24 h. pseudoaneurysms. It achieves excellent results and
From our initial experience we had no adjuvant use does not preclude another intervention and we re-
commend it as the primary treatment of choice.of UGCR or surgical conversions. This is in contrast
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